Sign In
Buy COLL
$31.06
+0.580 (+1.90%)
At Close: Jun 03, 2026
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
09:36pm, Friday, 13'th Mar 2020
Needham analyst Serge Belanger maintained a Hold rating on Amphastar Pharmaceuticals (AMPH) today. The company's shares closed last Monday at $14.19,
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
09:36pm, Friday, 13'th Mar 2020
Needham analyst
Serge Belanger
maintained a
Hold
rating on Amphastar Pharmaceuticals (
AMPH
–
Research Report
) today. The company’s shares closed last Monday at $14.19, close to its 52-week low o
The "Low Back Pain Clinical Trials Review: H1, 2020" report has been added to ResearchAndMarkets.com's offering.
Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (COLL) and Homology Medicines (FIXX)
01:53pm, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Collegium Pharmaceutical (COLL) and Homology Medicines
Analysts Offer Insights on Healthcare Companies: Collegium Pharmaceutical (NASDAQ: COLL) and Homology Medicines (NASDAQ: FIXX)
01:53pm, Friday, 13'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Collegium Pharmaceutical
Analysts' Opinions Are Mixed on These Healthcare Stocks: Inovio Pharmaceuticals (INO), Tetraphase (TTPH) and BioDelivery (BDSI)
11:22am, Friday, 13'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Inovio Pharmaceuticals (INO), Tetraphase (TTPH) and
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Inovio Pharmaceuticals (INO
Analysts Are Bullish on These Healthcare Stocks: Lineage Cell Therapeutics (LCTX), Menlo Therapeutics (MNLO)
11:16am, Friday, 13'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lineage Cell Therapeutics (LCTX), Menlo Therapeutics (MNLO)
Atria Investments LLC Sells 2,968 Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL)
09:12am, Friday, 13'th Mar 2020
Atria Investments LLC trimmed its position in shares of Collegium Pharmaceutical Inc (NASDAQ:COLL) by 12.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and
Barclays PLC Purchases 7,753 Shares of Collegium Pharmaceutical Inc (NASDAQ:COLL)
08:36am, Friday, 13'th Mar 2020
Barclays PLC grew its position in Collegium Pharmaceutical Inc (NASDAQ:COLL) by 31.8% in the fourth quarter, Holdings Channel.com reports. The fund owned 32,161 shares of the specialty pharmaceutical
Collegium Pharmaceutical (NASDAQ:COLL) Downgraded by BidaskClub
06:56am, Friday, 13'th Mar 2020
Collegium Pharmaceutical (NASDAQ:COLL) was downgraded by investment analysts at BidaskClub from a “hold” rating to a “sell” rating in a report issued on Friday, BidAskClub reports. COLL has be
SCYNEXIS (SCYX) Gets a Buy Rating from H.C. Wainwright
11:13am, Thursday, 12'th Mar 2020
H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on SCYNEXIS (SCYX) today and set a price target of $3.50. The company's shares closed last
SCYNEXIS (SCYX) Gets a Buy Rating from H.C. Wainwright
11:13am, Thursday, 12'th Mar 2020
H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on SCYNEXIS (SCYX – Research Report) today and set a price
Analysts Offer Insights on Healthcare Companies: Entasis Therapeutics Holdings (ETTX) and Zynerba Pharmaceuticals (ZYNE)
11:13am, Thursday, 12'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entasis Therapeutics Holdings (ETTX) and Zynerba
Analysts Offer Insights on Healthcare Companies: Entasis Therapeutics Holdings (NASDAQ: ETTX) and Zynerba Pharmaceuticals (NASDAQ: ZYNE)
11:13am, Thursday, 12'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Entasis Therapeutics Holdings (
ETTX
–
Research Report
) and Zynerba Pharmaceuticals (
ZYNE
–
Resea
